chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients received an improperly stored dose of (Oka/Merck) VARIVAX (lot # M006731, expiration date 09-FEB-2018l; lot# M017291, expiration date 07-APR-2018, dose and route were unknown). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
2" round red blotch, area is warm to touch, swelling, soreness.  Headache from day 1-8, tiredness
Pt called the office crying stating that she has extreme pain in her right arm where she received the injections and she is unable to move her right arm. She also explained that it was red, swollen, and had red blotchy marks on it. She was advised to go to the ED where they obtained labs and EKG and did an assessment. They did not find any acute bony abnormality or acute abscess in the area.
DIZZINESS; NAUSEA; This spontaneous report received from a consumer concerned multiple patients. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced dizziness. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea and dizziness was not reported. This report was non-serious.
14mins post vaccination pt c/o flushing/sweating.  Vitals: BP 129/72, HR 85, RR 18, Temp 97.3F Symptoms resolved.  Pt stable and released from the vaccination site.
6month old infant developed fever 103 and screaming episode for approximately 3 hrs following DTP/OPV immuniation
Patient presented for his 2nd dose of COVID vaccine on 12/3/21.  The clinic administered Pfizer vaccine 0.3 mL. Immediately after vaccine was given it was discovered that the patient received his 1st dose of COVID vaccine as Moderna, not Pfizer. He received the Moderna vaccine on 8/31/21.  Patient should have been given Moderna as his 2nd dose on 12/3/21, but instead was given Pfizer. Patient was made aware of this on 12/3/21 immediately after error was discovered.
Vaccine recipient returned to her residence via personal vehicle (as a passenger) and began to complain of moderate-severe nausea prior to exiting the vehicle. No emesis occurred, but she requested medicinal intervention with an antiemetic (Ondansetron) before attempting to enter the house. The medication was administered as requested by her daughter who is a nurse and her primary caregiver. After the medication took effect, the vaccine recipient ceased to complain of any further nausea. No other adverse symptoms were reoprted.
The patient received dose #1 of Pfizer (6mo-4y) on 07/06/2022  The patient returned on day 07/27/2022  and was inadvertently administered Moderna (6mo-5y)."
Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). On 18-May-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: follow up received-no new information found
Patient was admitted on 4/5/21 and was fully vaccinated for COVID-19. During admission, patient was managed/treated for COPD and a COVID-19 infection. Patient was  discharged from on 4/10/2021
Achy joints, especially hips started 5/30 AM, Sore/itchy throat started later 5/30 afternoon,  both continued through 5/31, mild temp(99.0-99.3) on 5/31 before bed, achy joints resolved on 6/1, but sore/scratchy throat with some drainage remained.
Patient was seen for a covid-19 vaccine. Patient's parent filled out the consent form and the demographic form and entered the DOB on both forms.  the nurse verified the DOB with the patient/parent and changed the DOB on the consent sheet because that is what she was advised when asking the patient.  (Front Staff) then called the Mom,  to clarify the date of birth of patient.  Mom stated they lied about her daughter?s date of birth and made a parental decision to have her daughter get the vaccine early and changed her birthday, her actual DOB . (Practice Manager) called person from County and was advised not to give the patient the second dose.  The second dose can only be given after the patient turns twelve.  We were also advised to enter the vaccine into MCIR and fill out a VAERS form.  The VAERS form was submitted on 5/21/2021. (Practice Manager) reached out to the Mom,  to advise her that patients second Covid-19 appointment will be canceled.  She was also advised if the insurance comes back and denies payment of the vaccine; she will be held responsible for the amount that is due.  mom asked when patient can get the second dose and I advised her she had to wait until patient turns 12 years old.  She asked if the patient would have to restart the vaccine.  I advised her I cannot answer that because she does not fall into the guidelines and would have to reach out to the county and I provided her with the number to reach County Covid-19.  At this time there are no adverse reactions to report.
Angioedema - Right eye very rapidly swelled shut. I already had sore throat,  Non-specific myalgias, and a temp of 38.6, mild rigors. I have never experienced angioedema before. I rapidly chewed 60mg  of Diphenhydramine. Seelling of eye went down over next hour or so. I have had no reoccurrence of facial swelling at this time.I am still having the fever and myalgias, but they seem fairly mild. Aside from the Benadryl I took nothing for treatment. Notified my PCP
Pt had rash that started the day after the second dose of COVID vaccine. Patient stated that she started experiencing a rash on her bilateral legs and bilateral arms and her face, pt stated that it was itchy. Patient stated that she went to her doctor who informed her to continue with OTC Benadryl liquid along with a oral antihistamine. Patient stated that is was getting better over time. Patient stated that they were informed that there was no any PCN in the COVID vaccine.
first dose on JUL-2021, not received second; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (Received 1st dose on 16th July 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable to this report. Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient was requesting information regarding the recommendation for patients who had waited longer than 6 months for their second dose. The reporter provided medical advice disclaimer. Spoke from Shingrix FAQs content. The patient declined to provide address, date of birth date and consent to contact her health care professional. The reporter did not consent to follow-up.
having a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (having a cold) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced NASOPHARYNGITIS (having a cold). At the time of the report, NASOPHARYNGITIS (having a cold) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient treatment includes Theraflu tea to help relieve symptoms.
Fever that evening. Vomited one time 2 days later. Rash on trunk 3 days later. Rash spread to arms and legs 4 days later with increased fussiness. Rash had Roseola type pattern along with the typical course of rash after fever for roseola.
pt recv vax 01JUN05 & 14JUN95 pt devel chickenpox; No further details were provided;
Per Dr.: Left thigh area of erythema was outlined with a pen. There is a mild increase in heat and tenderness but no localized blanching or reaction. 12 x 14 cm area. It became red and painful. He is still walking normally.
pt recv vax;w/in 24 hrs,devel fever of 105 which persisted for 5 days;fussy & irritable but no oth sx;fever responding to anti-pyretics;
Patient was admitted to the hospital with abdominal pain,nausea, vomiting on 9/2/21. Diagnosed with COvid-19 and perforated gastric ulcer.  Had open abdominal surgery and admitted to ICU post-operatively on the ventilator.  She developed ventilator associated pneumonia and was not able to successfully wean from ventilator and POA moved to comfort measures only on 9/14/21.   Patient died on comfort measures.
CRAMPS IN LEFT LEG AND FOOT; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 04-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced cramps in left leg and foot. On MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on MAR-2021, and the outcome of cramps in left leg and foot was not reported. This report was non-serious.
Patient received pfizer vaccine on 7/1/21 and 7/22/21. Presented to ER on 5/21/22 and found to be COVID19 positive.  presented to an outside hospital complaining of  difficulty getting around.  He lives with family.  He is retired.   Upon arrival to the emergency room there, oxygenation was in the 70s.  He did  receive a vaccination for COVID.  He did not get his booster.  He had a workup  at the outside hospital after being found to be hypoxic.  Found to have acute  hypercapnic respiratory failure with a pH 7.2, pCO2 was 66.  Patient was kept  on BiPAP.  He was found to have a BNP of 720.  Found to have bilateral  effusions, worse on the right.  He was given Lasix.  Also had a CT concerning  for possible right middle lobe pneumonia.  He did receive Lasix.  He was  unable to tolerate BiPAP, transferred on a nasal cannula.  Seen and examined  in the medical ICU where he is in no obvious distress on nasal cannula.  Will  have a stat ABG.  No previous history of any pleural effusions.  No history of  CHF.  Admits to compliance to medications.  No recent weight loss.  Does have  lower extremity swelling.  Also received Zosyn.  At the other hospital was  found to be hypothermic, was placed on a Bair Hugger.  Upon arrival here, his  temperature was found to be 97.  Blood pressure and heart rate are adequate at  this time.admitted on May 21st with acute hypoxic and hypercapnic respiratory failure.  Patient was diagnosed with COVID and also had superimposed bacterial pneumonia.  Patient was placed on BiPAP started IV steroids IV antibiotics.  Patient also had evidence fluid overload chest x-ray and started IV Lasix possible CHF.Patient underwent bilateral thoracocentesis on 05/23/2022 with removal of 1.2 L on the right sent 600 cc on the left.  Pleural fluid studies consistent with transudate. Patient had elevated D-dimer, unable to do CTA due to poor renal venous Doppler is negative and echo shows 45-50% EF.Pulmonary and Cardiology was consulted.  Patient had an echocardiogram which showed EF of 45-50%.  Cardiology started patient on beta blocker.  Losartan was put on hold.  Patient kidney function was also elevated which is now stable around creatinine of 1.8.   For code infectious Disease was consulted and patient is from his room to severe and dexamethasone course. Sputum culture grew extended spectrum cephalosporin resistant E coli.  Patient was treated with IV meropenem. Discharged on 6/3/22
Client received MENACTRA at school based IZ clinic, approx. ten minutes later, child was sitting in a chair by mom in another area of the clinic, stated she "felt sick, fainted and fell on the floor, hitting right side of her head," child opened her eyes, was responsive and alert. EMS was called and child was taken to ER per parent request.
pt recvd vax;glands under arms,began to swell 2 days later;severe aching of back & shoulder (rt);to MD,felt it was rxn to flu vax;sxs resolved;
Day #1 post vaccination patient had red, itchy arm from shoulder to wrist on right side.  Resolved on day #2 after vaccination.
Came down with Bell's palsy symptoms 5 days after injection on the Right side of my face.; This is a spontaneous report from a contactable consumer reported for himself. A 52-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 27Mar2021 (Lot Number: ER8732) as single dose for covid-19 immunisation.  The patient previously took the first dose bnt162b2 on 06Mar2021 for covid-19 immunization. The patient medical history included allergies to penicillin.   The patient's concomitant medications were not reported.  The patient came down with bell's palsy symptoms 5 days after injection on the right side of face on 01Apr2021 06:00. Facial paralysis resulted in emergency room visit. Therapeutic measures were taken as a result of facial paralysis included Steroid and Viral scripts. The outcome of event was unknown. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination.
DX: Cellulitis. Left upper medial leg with approx 4cmx4cm area of erythema surrounding most medial vaccine injection site. Treated with po abx, Augmentin 400mg 15mls, 3mls BID x 7 days.
There were no medical adverse events. The only purpose of this report is to inform VAERS that the patient was accidently administered a Moderna vaccine at an age less than 18 years old. She was 17 years old at the time of administration.
Pt. received Tdap 8/16/07, that night pt had diarrhea and felt nauseous, experienced 'heart racing'. On 8/22/07 pt came in for doctors appt due to continued diarrhea, body aches, nausea, and rt. ear pain. Also, site of injection very red, swollen, warm to touch and painful. Area of redness/swelling around injection site approx. 4inx3in. Pt. treated with Keflex.
extreme depression lasted me for 2-3 days; arm pain for about 2-3 days; drowsiness; irritable bowel like an upset stomach; irritable bowel like an upset stomach; feeling predominant sadness; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (extreme depression lasted me for 2-3 days), PAIN IN EXTREMITY (arm pain for about 2-3 days), SOMNOLENCE (drowsiness), IRRITABLE BOWEL SYNDROME (irritable bowel like an upset stomach) and ABDOMINAL DISCOMFORT (irritable bowel like an upset stomach) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEPRESSION (extreme depression lasted me for 2-3 days), PAIN IN EXTREMITY (arm pain for about 2-3 days), SOMNOLENCE (drowsiness), IRRITABLE BOWEL SYNDROME (irritable bowel like an upset stomach), ABDOMINAL DISCOMFORT (irritable bowel like an upset stomach), DEPRESSED MOOD (feeling predominant sadness), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DEPRESSION (extreme depression lasted me for 2-3 days), PAIN IN EXTREMITY (arm pain for about 2-3 days), SOMNOLENCE (drowsiness), IRRITABLE BOWEL SYNDROME (irritable bowel like an upset stomach), ABDOMINAL DISCOMFORT (irritable bowel like an upset stomach), DEPRESSED MOOD (feeling predominant sadness), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
MILDLY RED AND SWOLLEN, LATER IN DAY DARK ERYTHEMA AND HYPERPIGMENTATED, TODAY THIS A.M BLISTERS AND OOZING SWELLING PROGRESSING THIS A.M SILVADENE DRESSING BENADRYL IN THE OFFICE, PREDNISOLONE AND KEFLEX PRESCRIPTION.
Extreme Nausea lasting 4 days, headache lasting 5 days, dizziness lasting 5 days, shortness of breath on going, large rash on forearm of injected arm ongoing , large lump inside injected arm ongoing, very large disk shaped red rash at injection site ongoing, extreme fatigue and breathlessness also ongoing.
DELAYED MENSTRUAL CYCLE; TIRED; BODY SORENESS; FEVER; This spontaneous report received from a patient concerned a 19 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no change in lifestyle or medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A and expiry: 21-SEP-2021) dose was not reported, administered on 08-SEP-2021 for prophylactic vaccination. Concomitant medications included ethinylestradiol/norgestimate.  On 08-SEP-2021, the patient experienced body soreness. On 08-SEP-2021, the patient experienced fever. On 09-SEP-2021, the patient experienced tired. On 21-SEP-2021, the patient experienced delayed menstrual cycle. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body soreness, and fever on 09-SEP-2021, and had not recovered from tired, and delayed menstrual cycle. This report was non-serious.
No additional AE; Caller reporter improperly stored and administered vaccines for MMR-II, PROQUAD, and VARIVAX to multiple patients since May 2023 (TE occurred 5/9/2023). No symptoms reported. Caller did not have specific AE information available regarding patient inf; This spontaneous report was received from Other and refers to a 12-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 06-JUN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #W020540, expiration date: 28-JUN-2024, administered for prophylaxis (strength, and route of administration were not provided).This vaccine underwent temperature excursion before administration in 58.65 degree Farenheit (F) for 25 hours 45 minutes (Product storage error). No additional adverse event was reported.
Back hurting and fingers cramping up. Patient's back hurt and fingers are cramping. Problem remains one week later.
Following day 1 after vaccine given redness swollen hot to touch on injection site. By day 5 went away by day 8 came back redness bigger than before swelling warm to touch. After vaccine given stopped Imovan got better but came back. Arm keeps tingling will take Benadryl
has a knot in his throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL DISCOMFORT (has a knot in his throat) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Autism and GERD. Concurrent medical conditions included Drug allergy (Allergies to sulfa drugs.). Concomitant products included OMEPRAZOLE, ALPRAZOLAM (XANAX), GUANFACINE HYDROCHLORIDE (TENEX), CLONAZEPAM, DONEPEZIL HYDROCHLORIDE (ARICEPT), QUETIAPINE FUMARATE (SEROQUEL) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (has a knot in his throat). At the time of the report, OROPHARYNGEAL DISCOMFORT (has a knot in his throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Case comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This spontaneous report as received from an office administrator and a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (lot # M011116, expiration date 17-JUN-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced a temperature excursion of 72.5 degrees Fahrenheit for 5 hours. There were no previous excursions. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Infant received first dose of DTaP at 5 pm on 09/11/01. Infant awake screaming @ midnight which continued for a five minutes. After this infant become pale & listless. taken immediate to Urgent care by parents, no fever, neg. for infection per parents. @urgent care. discharge home after 1 hour with parents